Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

DCM vs IX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

IX Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 9–1 Matrix Metrics)

IX Overall Winner 6-Pillar Tally: DCM 0 – 5 IX (1 Tie) Matrix Metrics: DCM 1 – 9 IX

As of Nov 20, 2026, ORIX Corporation (IX) is the stronger overall head-to-head candidate over DCM (DCM) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DCM carries a Unified Composite Score of 48.8/100 (HOLD) at $2.82 (N/M Forward P/E, N/A operating margin), whereas IX carries 28.0/100 (SELL) at $32.01 (11.8x Forward P/E, 20.5% operating margin).

  • Composite vs. Pillar Nuance: While DCM currently prints a higher short-term Unified Composite Score (48.8/100 HOLD vs. IX 28.0/100 SELL), IX captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (20.5% vs. N/A operating margin) and revenue trajectory (+2.1% vs. N/A YoY).
  • Technical & Structure Timing Caution: DCM trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile IX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About DCM vs IX
DCM US Equity
DCM
Institutional Equity
$2.82
-6.62% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol N/A
Unified Composite Score
48.8 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A
IX NYSE Head-to-Head Winner
ORIX Corporation American Depositary Shares (each representing One (1) Share of Common Stock)
Miscellaneous Business Credit Institution
$32.01
-2.91% 1D
Market Cap $35.4B
TTM Revenue $19.8B
Forward P/E 11.8x
Beta / 30D Vol 0.92β · 27% Vol
Unified Composite Score
28.0 / 100 SELL
Tech 19.0 Fund 39.0 Flow 50.0 Mom 45.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.5%), weak momentum, RSI 27
RSI-14: 27.2 · SMA20: $34.97 · SMA50: $36.70

6-Pillar Scorecard Institutional Category Breakdown (DCM 0 – 5 IX)

Columns: Metric · DCM · IX
1. Valuation Multiples IX
Forward P/E N/M 11.8x
Trailing P/E N/M 6.0x
PEG Ratio N/M 2.72x
EV / Revenue N/M 1.8x
2. Growth & Scale IX
Revenue Growth (YoY) N/A +2.1%
Earnings Growth (YoY) N/A +263.3%
TTM Revenue (USD) N/A $19.8B
Market Cap N/A $35.4B
3. Profitability & Quality IX
Gross Margin N/A 44.2%
Operating Margin N/A 20.5%
Net Profit Margin N/A 29.7%
Return on Equity (ROE) N/A 19.7%
4. Balance Sheet & Cash Flow IX
Cash Generation (TTM) N/A $6.46B EBITDA
Cash Flow Margin N/A 32.7% EBITDA Mgn
Net Cash / Leverage N/A ROE $29.83 Book/Sh · 19.7% ROE
Dividend Yield None (0.00%) 1.18%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat IX
OpEx & R&D Intensity N/A 23.7% of Rev ($4.69B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Institutional Equity Operator Financial Conglomerates Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: DCM (1) vs IX (9)
Institutional Metric DCM IX Criterion Row Edge
Market Capitalization
Scale
N/A $35.4B Larger Scale IX
Trailing P/E Ratio
Valuation
N/M 6.0x Lower Multiple IX
Forward P/E Ratio
Valuation
N/M 11.8x Lower Multiple IX
Revenue Growth (YoY)
Growth
N/A +2.1% Higher Growth IX
Operating Margin (TTM)
Profitability
N/A 20.5% Higher Margin IX
Net Profit Margin
Profitability
N/A 29.7% Higher Margin IX
Return on Equity (ROE)
Capital Efficiency
N/A 19.7% Higher ROE IX
52-Week Range Position
Momentum
0% ($3–$5) 39% ($25–$42) Stronger Trend IX
Beta / 30D Volatility
Risk Regime
N/A 0.92β · 27% Vol Lower Realized Risk IX
Unified Institutional Score
Composite Signal
48.8 / 100 (HOLD) 28.0 / 100 (SELL) Higher Composite DCM
Trailing 12M Revenue (USD)
Operating Scale
N/A $19.8B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 44.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 2.72x PEG · 1.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) $6.46B EBITDA ($29.83 Book/Sh · 19.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon IX +13.92 pp
DCM: -26.75% · IX: -12.83%
3M Horizon IX +22.07 pp
DCM: -34.42% · IX: -12.35%
6M Horizon IX +22.07 pp
DCM: -34.42% · IX: -12.35%
1Y Horizon IX +22.07 pp
DCM: -34.42% · IX: -12.35%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DCM vs IX. Trailing 12-month operating profitability (DCM N/A vs IX 20.5%) and valuation multiples (DCM N/M vs IX 11.8x Forward P/E) are benchmarked directly in Pillar 4 below.

DCM ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
IX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$19.8B
Gross Margin44.2%
Op. Margin20.5%
ROE / Fwd P/E19.7% · 11.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
DCM UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DCM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
IX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
DCM Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
IX Moat Profile Scale & Operating Efficiency Moat
Financial Conglomerates Operator
Competes within the Financial Conglomerates value chain with $35.4B market capitalization and 20.5% operating margin.
OpEx & R&D Reinvestment 23.7% of Rev ($4.69B)
90D Engineering Disclosures 0 Published

Investor FAQ DCM vs IX Key Questions & Quantitative Answers

As of Nov 20, 2026, ORIX Corporation (IX) is the stronger overall head-to-head candidate over DCM (DCM) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DCM carries a Unified Composite Score of 48.8/100 (HOLD) at $2.82 (N/M Forward P/E, N/A operating margin), whereas IX carries 28.0/100 (SELL) at $32.01 (11.8x Forward P/E, 20.5% operating margin). Composite vs. Pillar Nuance: While DCM currently prints a higher short-term Unified Composite Score (48.8/100 HOLD vs. IX 28.0/100 SELL), IX captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (20.5% vs. N/A operating margin) and revenue trajectory (+2.1% vs. N/A YoY). Technical & Structure Timing Caution: DCM trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile IX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

IX leads the Growth & Scale pillar: DCM posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with IX at +2.1% YoY revenue growth and +263.3% YoY earnings growth on $19.8B TTM revenue (44.2% gross margin, 20.5% operating margin). On trailing 12-month operating scale, DCM generates N/A in USD-normalized revenue versus $19.8B for IX. In operating R&D and SG&A reinvestment, DCM deploys N/A (0 90-day corporate R&D disclosures) versus 23.7% of Rev ($4.69B) (0 disclosures) for IX.

IX screens cheaper on headline valuation multiples. DCM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas IX trades at 11.8x Forward P/E, 6.0x Trailing P/E, 2.72x PEG, and 1.8x EV/Revenue (32.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DCM (N/A ROE) versus IX (19.7% ROE) capital efficiency.

In options market volatility and institutional positioning, DCM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (N/A realized risk). By comparison, IX carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.92β · 27% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.